GCM
HZNP

Greenland Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Greenland Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-23,738
Closed -$2.75M – 583
2023
Q3 		$2.75M Buy
23,738
+9,149
+63% +$983K 0.27% 118
2023
Q2 		$1.5M Buy
14,589
+5,272
+57% +$556K 0.16% 148
2023
Q1 		$1.02M Sell
9,317
-50,576
-84% -$5.59M 0.11% 183
2022
Q4 		$6.82M Buy
+59,893
New +$4.97M 1.07% 24

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Greenland Capital Management's HZNP Position: Q4 2023 in Review

Greenland Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 23,738 shares — an estimated $2.75M sold.

Greenland Capital Management first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $6.82M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Greenland Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Greenland Capital Management sold 23,738 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.75M.
  • Greenland Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Greenland Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.82M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Greenland Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.